INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• The Power Of A Collaboration Platform

  Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.

• Citeline SmartSolutions

  Citeline SmartSolutions is a new generation of AI-powered clinical solutions including tools to recommend primary endpoints and inclusion/exclusion criteria and instantly generate a list of protocol-matched investigators for your trial.

• Real-Time Oversight, Less Site Burden: Orchestrated eCOA

  In this 10‑minute session you will learn how to simplify site tasks and improve the participant experience with the right eCOA system and Trial Coordinator.

• Everest Group Life Sciences eCOA Peak Matrix Assessment 2025

  Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.

• Better RTSM UX = Happy Clinical Trial Sites

  3/25/2026

  See how thoughtful RTSM design can ease site workloads, reduce support needs, and elevate staff satisfaction. Learn why intuitive user experiences quietly strengthen trial execution.

• What Most Psychiatric Drug Development Programmes Learn Too Late

  10/8/2026

  Clinical phase completion doesn’t end uncertainty. Six key questions on brain exposure, pharmacology, therapeutic window, and patient variability can reveal whether the molecule failed, or the mechanism.

• Data-Driven Automated Payments: Built For How Trials Actually Run

  8/18/2025

  A closer look at how data-driven automated payments reduce site burden, improve speed and accuracy, and create a smoother experience without adding operational complexity.

• Removing Translation Bottlenecks With AI

  8/8/2025

  See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.

• Pioneering The End-To-End Decentralized Trial Experience

  4/16/2025

  This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.